The Female Health Company to Expand Manufacturing Capacity for FC2 Female Condoms
CHICAGO, April 23, 2012 /PRNewswire via COMTEX/ -- The Female Health Company
(nasdaq-cm:FHCO) - today announced plans to install two more production lines for
its FC2 Female Condom? at its manufacturing facility in Malaysia.
"Recent increases in FC2 orders combined with the anticipated future demand have
triggered the expansion," said O.B. Parrish, Chief Executive Officer of The
Female Health Company. "With HIV/AIDS being the number one cause of death
globally for women aged 15-44 years, our major public sector customers report
increased focus on FC2's dual benefit of protection against both sexually
transmitted infections (including HIV/AIDS) and unintended pregnancy. Our goal is
to ensure that we are able to satisfy the expected growing demand for FC2."
"The expansion in Malaysia will bring the Company's total FC2 female condom
manufacturing capacity up to an annualized rate of approximately 100 million
units from the current annual capacity of approximately 85 million units" noted
Mike Pope, the Company's Vice President in charge of U.K. and Malaysian
operations.
The expansion is expected to be completed before calendar year end and will be
funded entirely with cash on hand.
About The Female Health Company
The Female Health Company, based in Chicago, Illinois, manufactures and markets
the FC2 Female Condom? (FC2), which is available in the U.S. and in about 130
other countries globally. The Company owns certain worldwide rights to the FC2
Female Condom?, including patents that have been issued in the U.S., the European
Union, Canada, Australia, South Africa, Japan, The People's Republic of China,
Spain, Mexico, Greece, Turkey and the African Regional Intellectual Property
Organization (ARIPO), which includes Botswana, The Gambia, Ghana, Kenya, Lesotho,
Malawi, Mozambique, Namibia, Sierra Leone, Somalia, Sudan, Swaziland, Uganda,
United Republic of Tanzania, Zambia and Zimbabwe. FC2 patent applications are
pending in various countries. The FC2 Female Condom? is the only available
FDA-approved product controlled by a woman that offers dual protection against
sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy. The
World Health Organization (WHO) has cleared FC2 for purchase by U.N. agencies.
"Safe Harbor" statement under the Private Securities Litigation Reform Act of
1995:
For more information about the Female Health Company visit the Company's website
at femalehealth.com and femalecondom.org. If you would like
to be added to the Company's e-mail alert list, please send an e-mail to
FHCInvestor@femalehealthcompany.com. |
